Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study
| Autor: | Buckley, Christopher D, Simón-Campos, Jesus A, Zhdan, Vyacheslav, Becker, Brandon, Davy, Katherine, Fisheleva, Elena, Gupta, Anubha, Hawkes, Carol, Inman, David, Layton, Mark, Mitchell, Nina, Patel, Jatin, Saurigny, Didier, Williamson, Russell, Tak, Paul P * |
|---|---|
| Zdroj: | In The Lancet Rheumatology November 2020 2(11):e677-e688 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|